Clinical trial

Low-Dose Dobutamine Tc-99m-Mibi Gated SPECT to Predict Left Ventricular…

NCT00487812 · University Hospital, Clermont-Ferrand, Other · Completed

Key facts

NCT number NCT00487812
Title Low-Dose Dobutamine Tc-99m-Mibi Gated SPECT to Predict Left Ventricular Remodelling in Patients Reperfused in the Acute Phase of MI
Official title Prediction of Left Ventricular Remodelling in Patients Treated by Angioplasty in the Acute of Phase of a First Myocardial Infarction by Low-Dose Dobutamine Tc-99m-Mibi Gated SPECT
Lead sponsor University Hospital, Clermont-Ferrand, Other
Status Completed
Study type Interventional
Conditions Ischemic Heart Disease, Myocardial Infarction
Intervention type Procedure
Interventions Low-dose dobutamine Tc-99-m-mibi gated SPECT imaging
Enrollment 50
Start date Dec 1, 2004
Primary completion Aug 1, 2006
Completion Sep 1, 2008
First posted Jun 19, 2007
Last update posted Oct 7, 2008
Countries France

At a glance

  • 1–9 Study sites
  • No Results posted
  • None Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies